Q3B(R) Impurities in New Drug Products (Revision 3)
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 4, 2006
September 29, 2021
a2e10295-fed5-4751-9af6-54da8d5c29c3
Related Documents
M4: The CTD -- Efficacy Questions and Answers
Guidance DocumentDecember 1, 2004Center for Drug Evaluation and Research
Q1A(R2) Stability Testing of New Drug Substances and Products
Guidance DocumentNovember 21, 2003Center for Drug Evaluation and Research
M4: The CTD -- General Questions and Answers
Guidance DocumentDecember 22, 2004Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox